GRAIL, Inc. Common Stock - relatórios financeiros trimestrais (NASDAQ:GRAL)

Abrir gráfico completo

Financials

Visão geral Relatórios Estatísticas

Trimestral Ano

Market Capitalization 2.57 B
Employee 910
Founded 2015
CEO N/A
Website www.grail.com
Headquarter Delaware, United States
FIGI BBG01N6CGW43
Industry Diagnósticos e pesquisa

Receita total

Lucro líquido

Lucro básico por ação

Dívida total

Fluxo de caixa livre

Caixa e equivalentes de caixa

Índice preço/lucro

-5.02

Índice preço/fluxo de caixa

12.35

GRAIL, Inc. - Common Stock

GRAIL, Inc. is an American biotechnology company based in Menlo Park, California founded in 2015 seeking to develop an early cancer screening test for people who do not have symptoms. As a startup it was a subsidiary of Illumina, which bought it outright in 2021. In June 2021 GRAIL launched their liquid biopsy, or multi-cancer early detection test, which they called Galleri test. In 2023 EU regulators ordered Grail to be spun-out from Illumina which was completed on June 24, 2024.